Combining with the focus of the 2023 national basic medical insurance, work injury insurance and maternity insurance drug catalog management, the State Medical Insurance Bureau released the "Negotiating Drug Contract Renewal Rules (2023 Edition)" and "Non-Exclusive Drug Bidding Rules ( Draft for Comments) to solicit opinions from the public.
Compared with the 2022 Negotiation Drug Contract Renewal Rules, the "Negotiation Drug Contract Renewal Rules (2023 Edition Consultation Draft)" has increased the conditions for being clearly included in the regular catalog management. The new conditions are: negotiation into the catalog and continuous inclusion Drugs in the "Negotiating Drug Part of the Agreement Period" of the catalog for more than 8 years (calculated from 2018 for the negotiated drugs in the 2017 version of the catalog, calculated from 2019 for the negotiated drugs in the 2018 version of the catalog, and calculated according to the implementation year of the catalog in 2019 and later).
The "Non-exclusive Drug Bidding Rules (Draft for Comment)" proposes that if a drug is included in the medical insurance catalog through bidding, the lowest price quoted by each company will be taken as the payment standard for the generic drug. If the company's quotation is lower than 70% of the medical insurance willingness to pay, 70% of the medical insurance willingness to pay will be used as the payment standard for the drug.
The public can put forward opinions and suggestions before 17:00 on July 10, 2023, and send feedback to the National Medical Insurance Administration in writing or email.
微信扫一扫打赏
